5.0
Jul 30, 2020
Current employee, more than 8 years
New York, NY
Recommend
CEO approval
Business Outlook
Pros
New CEO (since 2018) has been driving a positive empowering culture. Heavy investment and focus on digitization. Leadership in niche areas like nuclear medicine, cell and gene therapy etc. Science and innovation focus.
Cons
Radical and big bang changes with limited buy in favored in comparison with planned refinements. This applies to processes, talent moves, and business investment decisions